Education
About Us
Working with TipRanks
Follow Us
Oncimmune Holdings (GB:ONC)
LSE:ONC
ONC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.01 - $26.00
Previous CloseN/A
Volume18.00
Average Volume (3M)N/A
Market Cap
$1.27M
Enterprise ValueN/A
Total Cash (Recent Filing)$911.00K
Total Debt (Recent Filing)£5.26M
Price to Earnings (P/E)1.3
Beta0.56
Next Earnings
May 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding111,773,220
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)-0.52
Price to Sales (P/S)0.00
P/FCF Ratio-0.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Oncimmune Holdings News
PremiumCompany Announcements
Oncimmune Holdings Faces Administration and Adviser Resignations
PremiumCompany Announcements
Oncimmune Holdings Announces Change in Major Shareholder Voting Rights
PremiumCompany Announcements
Oncimmune Holdings to Enter Administration and Suspend Trading
PremiumCompany Announcements
Oncimmune Holdings Secures Strong Shareholder Support at General Meeting
PremiumCompany Announcements
Oncimmune Holdings Successfully Passes AGM ResolutionsPremiumCompany Announcements
Oncimmune Seeks Strategic Partnerships Amidst Financial ChallengesPremiumCompany Announcements
Oncimmune Holdings PLC Announce Changes in Shareholder Voting Rights
PremiumCompany Announcements
Oncimmune Announces General Meeting to Approve Financial ReportOptions Prices
Currently, No data available
---
Ownership Overview
1.56% Insiders
<0.01%
Mutual Funds
― Other Institutional Investors
98.44% Public Companies and
Individual Investors
ONC FAQ
What was Oncimmune Holdings’s price range in the past 12 months?
Oncimmune Holdings lowest share price was $1.01 and its highest was $26.00 in the past 12 months.
What is Oncimmune Holdings’s market cap?
Oncimmune Holdings’s market cap is $1.27M.
When is Oncimmune Holdings’s upcoming earnings report date?
Oncimmune Holdings’s upcoming earnings report date is May 28, 2025 which is 53 days ago.
How were Oncimmune Holdings’s earnings last quarter?
Currently, no data Available
Is Oncimmune Holdings overvalued?
According to Wall Street analysts Oncimmune Holdings’s price is currently Overvalued.
Does Oncimmune Holdings pay dividends?
Oncimmune Holdings does not currently pay dividends.
What is Oncimmune Holdings’s EPS estimate?
Oncimmune Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oncimmune Holdings have?
Oncimmune Holdings has 111,773,220 shares outstanding.
What happened to Oncimmune Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Oncimmune Holdings?
Currently, no hedge funds are holding shares in GB:ONC
Company Description
Oncimmune Holdings
Oncimmune Holdings (ONC) is a leading biotechnology company specializing in the early detection, diagnosis, and monitoring of cancer. The company operates within the healthcare sector, focusing on the development and commercialization of its proprietary EarlyCDT platform technology, which aids in detecting cancer early through a simple blood test. Oncimmune's core product offering includes EarlyCDT Lung, a test designed for the early detection of lung cancer, and other tests aimed at various cancer types.